Lineage to Report Second-Quarter 2025 Financial Results on August 6, 2025
A live webcast of the call will be available on the Lineage Investor Relations website at ir.onelineage.com. An audio replay of the conference call will be available for one week following the call and archived via webcast on the Lineage Investor Relations website at ir.onelineage.com for approximately one year.
About Lineage
Lineage, Inc. (NASDAQ: LINE) is the world's largest global temperature-controlled warehouse REIT with a network of over 485 strategically located facilities totaling approximately 86 million square feet and approximately 3.1 billion cubic feet of capacity across countries in North America, Europe, and Asia-Pacific. Coupling end-to-end supply chain solutions and technology, Lineage partners with some of the world's largest food and beverage producers, retailers, and distributors to help increase distribution efficiency, advance sustainability, minimize supply chain waste, and, most importantly, feed the world. Learn more at onelineage.com and join us on LinkedIn , Facebook , Instagram , and X.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250630564192/en/
Contacts
Investor Relations Contact Evan BarbosaVP, Investor Relationsir@onelineage.com
Media Contact Megan HendricksenVP, Global Marketing & Communicationspr@onelineage.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Horizon Bancorp, Inc. Announces Conference Call to Review Second Quarter Results on July 24
MICHIGAN CITY, Ind., July 01, 2025 (GLOBE NEWSWIRE) -- (NASDAQ GS: HBNC) – Horizon Bancorp, Inc. ('Horizon' or the 'Company') will host a conference call at 7:30 a.m. CT on Thursday, July 24, 2025 to review its second quarter 2025 financial results. The Company's second quarter 2025 news release will be published after markets close on Wednesday, July 23, 2025. It will be available at Participants may access the live conference call on July 24, 2025 at 7:30 a.m. CT (8:30 a.m. ET) by dialing 833-974-2379 from the United States, 866-450-4696 from Canada, or 412-317-5772 from international locations and requesting the 'Horizon Bancorp Call.' Please dial in approximately 10 minutes prior to the call. A telephone replay of the call will be available approximately one hour after the end of the conference call through August 1, 2025. The telephone replay may be accessed by dialing 877-344-7529 from the United States, 855-669-9658 from Canada, or 412-317-0088 from other international locations and entering the access code 5878909. About Horizon Bancorp, Inc. Horizon Bancorp, Inc. (NASDAQ GS: HBNC) is the $7.6 billion-asset commercial bank holding company for Horizon Bank, which serves customers across diverse and economically attractive Midwestern markets through convenient digital and virtual tools, as well as its Indiana and Michigan branches. Horizon's retail offerings include prime residential and other secured consumer lending to in-market customers, as well as a range of personal banking and wealth management solutions. Horizon also provides a comprehensive array of in-market business banking and treasury management services, as well as equipment financing solutions for customers regionally and nationally, with commercial lending representing over half of total loans. More information on Horizon, headquartered in Northwest Indiana's Michigan City, is available at and Contact: Mark E. Secor Chief Administration Officer Phone: 219-873-2611 Date: July 1, 2025Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Moolec Science Secures Core U.S. Patent for Piggy Sooy(TM), Soybean Expressing Up to 30% of Animal Protein
WARWICK, GB / / June 18, 2025 / Moolec Science Limited a wholly-owned subsidiary of Moolec Science SA (NASDAQ:MLEC; "The Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its proprietary groundbreaking Piggy Sooy™ technology - soybean plant engineered to express high levels of porcine hemeproteins in their seeds. Piggy Sooy™ is the first patented soybean technology designed to produce high levels of porcine hemeproteins directly in the seeds. The U.S. patent covers the plants and seeds, the method used to develop them, and food compositions derived from this breakthrough innovation. In April 2024, the USDA-APHIS confirmed that Piggy Sooy™ does not present plant pest risk difference from conventional soybeans, determining it is not subject to regulation under 7 CFR part 340 - a key regulatory milestone toward commercialization. Moolec's Chief Science Officer, Amit Dhingra, stated: "Initial field trials demonstrated promising production yield, with over 20% animal protein content in the total soluble protein fraction. Furthermore, the deployment of Piggy Sooy™ technology presents compelling environmental benefits when compared to traditional agricultural and meat production practices. One acre of Piggy Sooy™ has the potential capacity to produce the same amount of protein as approximately 10 pigs, using ~35x less land, generating ~8x less water footprint and ~60x less CO2 emissions. These multifaceted benefits make Piggy Sooy™ a game-changer in sustainable protein production." This patent provides Moolec with exclusive commercial rights to Piggy Sooy™ technology in the U.S. until 2042, significantly strengthening the Company's intellectual property portfolio. This is the first in a series of over fifteen patent applications filed globally aimed at protecting Moolec's Molecular Farming innovations. "Our experience has taught us that long-term success in biotechnology is built on securing robust, enforceable intellectual property. This patent validates Moolec's scientific leadership in Molecular Farming and protects a technology with unprecedented levels of animal protein expression in plants. It's not only a recognition of our innovation, but a vital asset that allows us to advance confidently toward commercialization and build a differentiated position in our food and feed ingredients business," said Alejandro Antalich, CEO of Moolec Science. Contact Information Press & Media comms@ Investor Relations ir@ SOURCE: Moolec Science View the original press release on ACCESS Newswire Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Should You Think About Buying National Beverage Corp. (NASDAQ:FIZZ) Now?
National Beverage Corp. (NASDAQ:FIZZ), might not be a large cap stock, but it received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$46.54 at one point, and dropping to the lows of US$40.18. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether National Beverage's current trading price of US$42.39 reflective of the actual value of the mid-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at National Beverage's outlook and value based on the most recent financial data to see if there are any catalysts for a price change. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Great news for investors – National Beverage is still trading at a fairly cheap price. According to our valuation, the intrinsic value for the stock is $66.68, which is above what the market is valuing the company at the moment. This indicates a potential opportunity to buy low. Another thing to keep in mind is that National Beverage's share price may be quite stable relative to the rest of the market, as indicated by its low beta. This means that if you believe the current share price should move towards its intrinsic value over time, a low beta could suggest it is not likely to reach that level anytime soon, and once it's there, it may be hard to fall back down into an attractive buying range again. View our latest analysis for National Beverage Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Though in the case of National Beverage, it is expected to deliver a relatively unexciting top-line growth of 4.6% in the next few years, which doesn't help build up its investment thesis. Growth doesn't appear to be a main reason for a buy decision for the company, at least in the near term. Are you a shareholder? Even though growth is relatively muted, since FIZZ is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. However, there are also other factors such as financial health to consider, which could explain the current undervaluation. Are you a potential investor? If you've been keeping an eye on FIZZ for a while, now might be the time to enter the stock. Its future outlook isn't fully reflected in the current share price yet, which means it's not too late to buy FIZZ. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed investment decision. So while earnings quality is important, it's equally important to consider the risks facing National Beverage at this point in time. Case in point: We've spotted 1 warning sign for National Beverage you should be aware of. If you are no longer interested in National Beverage, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
